Influenza A virus protein PB1-F2: Synthesis and characterization of the biologically active full length protein and related peptides

Journal of Peptide Science

Volumn 11, Issue 8, 2005, Pages 481-490

  Henklein, Peter ^a   Bruns, Karsten ^b,c   Nimtz, Manfred ^b   Wray, Victor ^b   Tessmer, Uwe ^c   Schubert, Ulrich ^c,d,e  

^a HUMBOLDT UNIVERSITY   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Chemical ligation; Influenza A virus protein PB1 F2; MALDI TOF mass spectrometry; Piperidide formation; Protein synthesis; TOCSY nuclear magnetic resonance spectroscopy

Indexed keywords

ASPARTIC ACID; CYSTEINE; HISTIDINE; PIPERIDINE DERIVATIVE; PROTEIN PB1 F2; SUCCINIMIDE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA VIRUS A; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MUTANT; NONHUMAN; OLIGOMERIZATION; OPEN READING FRAME; PEPTIDE MAPPING; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN SYNTHESIS; PROTON NUCLEAR MAGNETIC RESONANCE; WESTERN BLOTTING;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; PEPTIDE FRAGMENTS; PHOSPHORYLATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; VIRAL PROTEINS;

INFLUENZA A VIRUS;

EID: 23144452841     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.641     Document Type: Article

References (32)

1. Yewdell J, Garcia-Sastre A. Influenza virus still surprises. Curr. Opin. Microbiol. 2002; 5: 414-418.
2. Lamb RA, Takeda M. Death by influenza virus protein. Nat. Med. 2001; 7: 1286-1288.
3. Webster RG. Influenza virus: transmission between species and relevance to emergence of the next human pandemic. Arch. Virol. Suppl. 1997; 13: 105-113.
4. Webby RJ, Webster RG. Emergence of influenza A viruses. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2001; 356: 1817-1828.
5. Webster RG, Bean WJ Jr. Genetics of influenza virus. Annu. Rev. Genet. 1978; 12: 415-431.
6. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, Basta S, O'Neill R, Schickli J, Palese P, Henklein P, Bennink JR, Yewdell JW. A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med. 2001; 7: 1306-1312.
7. Lowy RJ. Influenza virus induction of apoptosis by intrinsic and extrinsic mechanisms. Int. Rev. Immunol. 2003; 61: 2001-2005.
8. D'Agostino DM, Ranzato L, Arrigoni G, Cavallari I, Belleudi F, Torrisi MR, Silic-Benussi M, Ferro T, Petronilli V, Marin O, Chieco-Bianchi L, Bernardi P, Ciminale V. Mitochondrial alterations induced by the p13II protein of human T-cell leukemia virus type 1. Critical role of arginine residues. J. Biol. Chem. 2002; 277: 34424-34433.
9. Silic-Benussi M, Cavallari I, Zorzan T, Rossi E, Hiraragi H, Rosato A, Horie K, Saggioro D, Lairmore MD, Willems L, Chieco-Bianchi L, D'Agostino DM, Ciminale V. Suppression of tumor growth and cell proliferation by p13II, a mitochondrial protein of human T cell leukemia virus type 1. Proc. Natl Acad. Sci. USA 2004; 101: 6629-6634.
10. Muthumani K, Hwang DS, Desai BM, Zhang D, Dayes N, Green DR, Weiner DB. HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells. J. Biol. Chem. 2002; 277: 37820-37831.
11. Sherman MP, Greene WC. Slipping through the door: HIV entry into the nucleus. Microbes Infect. 2002; 4: 67-73.
12. Gibbs JS, Malide D, Hornung F, Bennink JR, Yewdell JW. The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. J. Virol. 2003; 77: 7214-7224.
13. Chanturiya AN, Basanez G, Schubert U, Henklein P, Yewdell JW, Zimmerberg J. PB1-F2, an influenza A virus-encoded proapoptotic mitochondrial protein, creates variably sized pores in planar lipid membranes. J. Virol. 2004; 78: 6304-6312.
14. Henklein P, Bruns K, Sherman MP, Tessmer U, Licha K, Kopp J, de Noronha CM, Greene WC, Wray V, Schubert U. Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest. J. Biol. Chem. 2000; 275: 32016-32026.
15. Lauer J, Fields CG, Fields GB. Sequence dependence of aspartimide formation during 9-fluorylmethoxylcarbonyl solid-phase peptide synthesis. Lett. Pept. Sci. 1994; 1: 197-205.
16. Dawson PE, Muir TW, Clark-Lewis I, Kent SB. Synthesis of proteins by native chemical ligation. Science 1994; 266: 776-779.
17. von Eggelkraut-Gottanka R, Klose A, Beck-Sickinger AG, Beyermann M. Peptide α-thioester formation using standard Fmoc-chemistry. Tetrahedron Lett. 2003; 44: 3551-3554.
18. McGuffin W, Bryson K, Jones DT. The PSIPRED protein structure prediction server. Bioinformatics 2000; 16: 404-405.
19. Kneller DG, Cohen FE, Langridge R. Improvements in protein secondary structure prediction by an enhanced neural network. J. Mol. Biol. 1990; 214: 171-182.
20. Baldi P, Brunak S, Frasconi P, Soda G, Pollastri G. Exploiting the past and the future in protein secondary structure prediction. Bioinformatics 1999; 15: 937-946.
21. Ouali M, King RD. Cascade multiple classifiers for secondary structure prediction. Protein Sci. 2000; 9: 1162-1176.
22. Blom N, Gammeltoft S, Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 1999; 294: 1351-1362.
23. 15N-labeled amino acids for NMR structural studies. J. Pept. Res. 1999; 54: 427-435.
24. Henklein P, Schubert U, Kunert O, Klabunde S, Wray V, Kloppel KD, Kiess M, Portsmann T, Schomburg D. Synthesis and characterization of the hydrophilic C-tenninal domain of the human immunodeficiency virus type 1-encoded virus protein U (Vpu). Pept. Res. 1993; 6: 79-87.
25. Kochendoerfer GG, Jones DH, Lee S, Oblatt-Montal M, Opella SJ, Montal M. Functional characterization and NMR spectroscopy on full-length Vpu from HIV-1 prepared by total chemical synthesis. J. Am. Chem. Soc. 2004; 126: 2439-2446.
26. Kochendoerfer GG, Salom D, Lear JD, Wilk-Orescan R, Kent SB, DeGrado WF. Total chemical synthesis of the integral membrane protein influenza A virus M2: role of its C-terminal domain in tetramer assembly. Biochemistry 1999; 38: 11905-11913.
27. David R, Richter MP, Beck-Sickinger AG. Expressed protein ligation. Method and applications. Eur. J. Biochem. 2004; 271: 663-677.
28. Wilken J, Kent SB. Chemical protein synthesis. Curr. Opin. Biotechnol. 1998; 9: 412-426.
29. Schubert U, Strebel K. Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J. Virol. 1994; 68: 2260-2271.
30. Sugrue RJ, Hay AJ. Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel. Virology 1991; 180: 617-624.
31. Schagger H, von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 1987; 166: 368-379.
32. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.